Lundbeck Completes Patient Randomization in Phase...
Category : Clinical Trial Update 12 March 2026A major milestone has been reached in the search for treatments for Multiple System Atrophy (MSA)....
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Gesynta Pharma Begins Phase 2 Trial of Vipoglansta...
Category : Clinical Trial Update 12 March 2026Gesynta Pharma AB has announced that the first patient has been dosed in its Phase 2 clinical trial...
ASC30 Monthly Injection Shows Promising Weight Los...
Category : Clinical Trial Update 11 March 2026The race to develop next-generation obesity treatments continues to accelerate. A new investigationa...
Sevasemten Shows Long-Term Functional Stabilizatio...
Category : Clinical Trial Update 11 March 2026New long-term clinical data suggest that sevasemten, an investigational therapy for Becker muscular...
GDNF-Based Therapy Shows Promising Metabolic Benef...
Category : Clinical Trial Update 11 March 2026New preclinical research suggests that a GDNF-based therapy could improve lipid metabolism and prote...
Latest Newsletter Post
-
Gesynta Pharma Begins Phase 2 Trial..
12 March 2026
-
Lundbeck Completes Patient Randomiz..
12 March 2026
-
Eisai to Present New Lecanemab Data..
11 March 2026
-
POLY-ACS Trial Explores Polypill St..
11 March 2026
-
GDNF-Based Therapy Shows Promising..
11 March 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com